- Page 1 and 2: Antibiotics Simplified third EDITIO
- Page 3 and 4: Contents Acknowledgments Introducti
- Page 5 and 6: Contents v Chapter 28: Antifungal A
- Page 7: Acknowledgments Our thanks go to th
- Page 10 and 11: x Introduction ■■ How to Use Th
- Page 15: Considerations with Antibiotic Ther
- Page 18 and 19: 4 PART 1 Antibiotic Therapy Less li
- Page 20 and 21: 6 PART 1 Antibiotic Therapy Strepto
- Page 22 and 23: 8 PART 1 Antibiotic Therapy Gram-po
- Page 24 and 25: 10 PART 1 Antibiotic Therapy 2. Col
- Page 26 and 27: 12 PART 1 Antibiotic Therapy Gram-n
- Page 28 and 29: 14 PART 1 Antibiotic Therapy 2. Glu
- Page 30 and 31: 16 PART 1 Antibiotic Therapy Pathog
- Page 32 and 33: 18 PART 1 Antibiotic Therapy nature
- Page 34 and 35: 20 PART 1 Antibiotic Therapy • Az
- Page 36 and 37: 22 PART 1 Antibiotic Therapy TR’s
- Page 38 and 39: 24 PART 1 Antibiotic Therapy Peak c
- Page 40 and 41: 26 PART 1 Antibiotic Therapy A smal
- Page 42 and 43: 28 PART 1 Antibiotic Therapy of eff
- Page 44 and 45: 30 PART 1 Antibiotic Therapy be ant
- Page 47 and 48: Antibiotic Pharmacodynamics 4 The t
- Page 49 and 50: chapter 4 Pharmacodynamics 35 Visib
- Page 51 and 52: chapter 4 Pharmacodynamics 37 Stati
- Page 53: chapter 4 Pharmacodynamics 39 with
- Page 56 and 57: 42 PART 1 Antibiotic Therapy cross-
- Page 58 and 59: 44 PART 1 Antibiotic Therapy uses,
- Page 60 and 61: 46 PART 1 Antibiotic Therapy indica
- Page 63 and 64:
Beta-Lactams 6 ■■ Introduction
- Page 65 and 66:
Penicillins ■■ Introduction to
- Page 67 and 68:
Natural Penicillins Agents: penicil
- Page 69:
chapter 6 Beta-Lactams 55 penicilli
- Page 72 and 73:
58 PART 2 Antibacterial Drugs Adver
- Page 74 and 75:
60 PART 2 Antibacterial Drugs Adver
- Page 77 and 78:
Antipseudomonal Penicillins Agents:
- Page 79 and 80:
Beta-Lactamase Inhibitor Combinatio
- Page 81 and 82:
chapter 6 Beta-Lactams 67 ■■ Im
- Page 83 and 84:
Cephalosporins ■■ Introduction
- Page 85 and 86:
First-Generation Cephalosporins Age
- Page 87 and 88:
Second-Generation Cephalosporins Ag
- Page 89:
chapter 6 Beta-Lactams 75 What They
- Page 92 and 93:
78 PART 2 Antibacterial Drugs assoc
- Page 95 and 96:
Fourth-Generation Cephalosporins Ag
- Page 97 and 98:
Fifth-Generation Cephalosporins Age
- Page 99 and 100:
chapter 6 Beta-Lactams 85 Don’t F
- Page 101 and 102:
88 PART 2 Antibacterial Drugs Moder
- Page 104 and 105:
Monobactams Agent: aztreonam Aztreo
- Page 106 and 107:
Glycopeptides 7 Agents: vancomycin,
- Page 108 and 109:
chapter 7 Glycopeptides 95 was brow
- Page 110 and 111:
Fluoroquinolones 8 Agents: ciproflo
- Page 112 and 113:
chapter 8 Fluoroquinolones 99 Devel
- Page 114 and 115:
102 PART 2 Antibacterial Drugs Spec
- Page 116 and 117:
102 PART 2 Antibacterial Drugs Spec
- Page 118 and 119:
104 PART 2 Antibacterial Drugs by s
- Page 120 and 121:
106 PART 2 Antibacterial Drugs Spec
- Page 122 and 123:
108 PART 2 Antibacterial Drugs syph
- Page 124 and 125:
110 PART 2 Antibacterial Drugs Spec
- Page 126 and 127:
112 PART 2 Antibacterial Drugs Don
- Page 128 and 129:
114 PART 2 Antibacterial Drugs Adve
- Page 131 and 132:
Nitroimidazoles 13 Agents: metronid
- Page 133:
chapter 13 Nitroimidazoles 119 •
- Page 136 and 137:
122 PART 2 Antibacterial Drugs Spec
- Page 139 and 140:
Streptogramins 15 Agent: quinuprist
- Page 141:
chapter 15 Streptogramins 127 What
- Page 144 and 145:
130 PART 2 Antibacterial Drugs Adve
- Page 147 and 148:
Folate Antagonists 17 Agents: trime
- Page 149 and 150:
chapter 17 Folate Antagonists 135
- Page 151 and 152:
Lincosamides 18 Agent: clindamycin
- Page 153 and 154:
chapter 18 Lincosamides 139 these i
- Page 155 and 156:
Polymyxins 19 Agents: colistin (col
- Page 157 and 158:
chapter 19 Polymyxins 143 base coli
- Page 159 and 160:
Fidaxomicin 20 Agent: fidaxomicin F
- Page 161:
Antimycobacterial Drugs Part 3
- Page 164 and 165:
150 PART 3 Antimycobacterial Drugs
- Page 167 and 168:
Rifamycins 22 Agents: rifampin (aka
- Page 169 and 170:
chapter 22 Rifamycins 155 it is mor
- Page 171 and 172:
Isoniazid 23 Agent: isoniazid Isoni
- Page 173:
chapter 23 Isoniazid 159 Don’t Fo
- Page 176 and 177:
162 PART 3 Antimycobacterial Drugs
- Page 178 and 179:
164 PART 3 Antimycobacterial Drugs
- Page 181 and 182:
Antifungal Drugs 26 ■■ Introduc
- Page 183:
chapter 26 Antifungal Drugs 169 fun
- Page 186 and 187:
172 PART 4 Antifungal Drugs Spectru
- Page 188 and 189:
174 PART 4 Antifungal Drugs What Th
- Page 190 and 191:
176 PART 4 Antifungal Drugs Adverse
- Page 193:
Azoles 29 ■■ Introduction to Az
- Page 196 and 197:
182 PART 4 Antifungal Drugs Adverse
- Page 199 and 200:
Itraconazole Itraconazole is a broa
- Page 201:
chapter 29 Azoles 187 What It’s G
- Page 204 and 205:
190 PART 4 Antifungal Drugs Moderat
- Page 206 and 207:
192 PART 4 Antifungal Drugs Don’t
- Page 208 and 209:
194 PART 4 Antifungal Drugs Adverse
- Page 211 and 212:
Echinocandins 30 Agents: caspofungi
- Page 213:
chapter 30 Echinocandins 199 clinic
- Page 217 and 218:
Antiviral Drugs 31 ■■ Introduct
- Page 219:
chapter 31 Antiviral Drugs 205 read
- Page 222 and 223:
208 PART 5 Antiviral Drugs Adverse
- Page 225 and 226:
Anti-Cytomegalovirus Agents 33 Agen
- Page 227:
chapter 33 Anti-CMV Agents 213 Ganc
- Page 230 and 231:
216 PART 5 Antiviral Drugs Adverse
- Page 233 and 234:
Antiretroviral Drugs 35 ■■ Intr
- Page 235 and 236:
Nucleoside and Nucleotide Reverse T
- Page 237 and 238:
chapter 35 Antiretroviral Drugs 223
- Page 239 and 240:
Non-nucleoside Reverse Transcriptas
- Page 241 and 242:
chapter 35 Antiretroviral Drugs 227
- Page 243 and 244:
Protease Inhibitors Agents: atazana
- Page 245 and 246:
chapter 35 Antiretroviral Drugs 231
- Page 247:
chapter 35 Antiretroviral Drugs 233
- Page 250 and 251:
236 PART 5 Antiviral Drugs Adverse
- Page 253 and 254:
Entry and Fusion Inhibitors Agents:
- Page 255 and 256:
Antiviral Interferons 36 Agents: pe
- Page 257 and 258:
chapter 36 Antiviral Interferons 24
- Page 259 and 260:
Serine Protease Inhibitors 37 Agent
- Page 261 and 262:
chapter 37 Serine Protease Inhibito
- Page 263 and 264:
Ribavirin 38 Agents: ribavirin Riba
- Page 265:
chapter 38 Ribavirin 251 What They
- Page 268 and 269:
254 PART 5 Antiviral Drugs Adverse
- Page 271 and 272:
Antiparasitic Drugs 40 ■■ Intro
- Page 273:
chapter 40 Antiparasitic Drugs 259
- Page 276 and 277:
262 PART 6 Antiparasitic Drugs abil
- Page 278 and 279:
264 PART 6 Antiparasitic Drugs worl
- Page 280 and 281:
266 PART 6 Antiparasitic Drugs ■
- Page 283 and 284:
Benzimidazoles 43 Agents: albendazo
- Page 285:
chapter 43 Benzimidazoles 271 Don
- Page 288 and 289:
274 PART 6 Antiparasitic Drugs QT p
- Page 291 and 292:
Ivermectin 45 Agent: ivermectin If
- Page 293 and 294:
chapter 45 Ivermectin 279 What It
- Page 295 and 296:
appendix 1 Normal Human Flora 281 S
- Page 297 and 298:
appendix 2 Spectrum of Activity 283
- Page 299 and 300:
appendix 2 Spectrum of Activity 285
- Page 301 and 302:
appendix 2 Spectrum of Activity 287
- Page 303 and 304:
appendix 3 Empiric Regimens 289 Hea
- Page 305 and 306:
appendix 3 Empiric Regimens 291 Int
- Page 307 and 308:
Index A A. baumannii, 12-14, 67, 91
- Page 309 and 310:
Index 295 Aribinosyl transferase II
- Page 311 and 312:
Index 297 anaerobes and, 71, 73-75,
- Page 313 and 314:
Index 299 Drug-resistant organisms,
- Page 315 and 316:
Index 301 cephalosporins and, 71, 7
- Page 317 and 318:
Index 303 L Lactic acidosis, 114, 2
- Page 319 and 320:
Index 305 polyenes and, 171, 172, 1
- Page 321 and 322:
Index 307 Plasmodium, 5, 106, 138,
- Page 323 and 324:
Index 309 Seizures, 118, 154, 158,
- Page 325:
Index 311 Valganciclovir, described